
4J Therapeutics – FreeMind Elite
January 6, 2025/by Ayal Ronen
NIH Funding during the first Trump Administration; Driving Growth in Non-Basic Research and Supporting the Life Sciences Industry
December 18, 2024/by Ayal Ronen
4J Therapeutics Secures Major BARDA Contract
November 6, 2024/by Ayal Ronen
Grant Tips & Tricks: Straight from the FreeMind Group Experts
October 10, 2024/by Ayal Ronen
LSX Nordic Congress, October 8-9, 2024, Copenhagen, Denmark
September 29, 2024/by Ayal Ronen
Cell & Gene on the Mesa, October 7-9, 2024, Phoenix, AZ
September 29, 2024/by Ayal Ronen
LSX RNA Leaders, September 4-5, 2024, San Diego
July 24, 2024/by Ayal Ronen
LSX World Congress USA, September 11-12, 2024, Boston
July 15, 2024/by Ayal Ronen
Why Should the Government Fund R&D?
July 15, 2024/by Ayal Ronen
The MedTech Conference, October 15-17, Toronto
June 23, 2024/by Ayal Ronen
The Benefits of Non-Dilutive Funding
June 19, 2024/by Ayal Ronen
BioFuture, October 28-30, 2024, NYC
June 5, 2024/by Ayal RonenSearch
Recent Posts
Sachs Associates Oncology Innovation Forum, January 10, 2026, San FranciscoDecember 15, 2025 - 11:11 am
RESI JPM, January 12-13, 2026, San FranciscoDecember 15, 2025 - 11:02 am
Biotech Showcase, January 12-14, 2026, San FranciscoDecember 15, 2025 - 10:58 am
The Largest Funder of Life Science Companies You are IgnoringNovember 17, 2025 - 12:14 pm
RESI, December 4, 2025, LondonOctober 19, 2025 - 11:48 am
